{"chunk_id": "WHO_GUIDELINES(TRAIN DATA)__chunk_635", "source": "WHO_GUIDELINES(TRAIN DATA)", "text": "antenatal anti-D prophylaxis. One \ntrial used a dose of 500 IU, the other used 250 IU, \ngiven at 28 and 34 weeks of gestation. Data were \navailable for 3902 pregnancies, and more than half \nthe participants gave birth to Rh-positive newborns \n(2297). All women with Rh-positive newborns \nreceived postpartum anti-D immunoglobulin as per \nusual management. The primary outcome was the \npresence of Rh-antibodies in maternal blood (a proxy \nfor neonatal morbidity). No maternal ANC guideline \noutcomes"}